2nd Quarter - Report
CSL BEHRING LLC for CSL BEHRING LLC
Firm
Client
Income
—
Expenses
$170,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Preserving Access to Orphan Drugs Act (HR 2315/S.1128) Orphan Drug Tax Credit - highlighting its importance in orphan product development for treatment of rare diseases
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN R. BULLARD | — |
| PATRICK COLLINS | — |
| DENNIS JACKMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.